Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

COVENTRY GROUP LIMITED Capital/Financing Update 2019

Oct 28, 2019

64742_rns_2019-10-28_958de0a8-d37c-4971-a835-b07061138b6b.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

==> picture [82 x 14] intentionally omitted <==

==> picture [154 x 14] intentionally omitted <==

Appendix 3B

New issue announcement, application for quotation of additional securities and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13

Name of entity

Coventry Group Limited

ABN

37 008 670 102

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

1
+Class of+securities issued or to be
issued
2
Number of+securities issued or to be
issued (if known) or maximum number
which may be issued
3
Principal terms of the+securities (e.g. if
options, exercise price and expiry date;
if partly paid+securities, the amount
outstanding
and
due
dates
for
payment; if+convertible securities, the
conversion price and dates for
conversion)
Performance Rights
1,164,237
Pursuant to the Company’s Executive and Director
Incentive Plan (“the Plan”), the Performance Rights
have been issued to the eligible participants of the
Company. The issue of Performance Rights to the
Managing Director was approved by the shareholders
at the Annual General Meeting (“AGM”) of the
Company on 25 October 2019.
Key terms relating to the grant of Performance Rights
to the eligible participants are provided in the
Coventry’s Notice of 2019 AGM.
Upon meeting applicable hurdles, the Performance
Rights will each vest into one fully paid ordinary share.
All Performance Rights that vest in accordance with
the Plan are exercisable into shares over three (03)
yearsinequal lots.

==> picture [162 x 12] intentionally omitted <==

==> picture [61 x 11] intentionally omitted <==

==> picture [94 x 11] intentionally omitted <==

==> picture [82 x 14] intentionally omitted <==

==> picture [154 x 14] intentionally omitted <==

4
Do the+securities rank equally in all
respects from the+issue date with an
existing+class of quoted+securities?
If the additional+securities do not rank
equally, please state:
 the date from which they do
 the extent to which they participate
for the next dividend, (in the case of
a trust, distribution) or interest
payment
 the extent to which they do not rank
equally, other than in relation to the
next
dividend,
distribution
or
interest payment
5
Issue price or consideration
6
Purpose of the issue
(If issued as consideration for the
acquisition of assets, clearly identify
those assets)
6a
Is the entity an+eligible entity that has
obtained security holder approval under
rule 7.1A?
If Yes, complete sections 6b – 6h_in_
relation to the+securities the subject of
this Appendix 3B, and comply with
section 6i
6b
The date the security holder resolution
under rule 7.1A was passed
6c
Number of+securities issued without
security holder approval under rule 7.1
6d
Number of+securities issued with
security holder approval under rule
7.1A
6e
Number of+securities issued with
security holder approval under rule 7.3,
or another specific security holder
approval (specify date of meeting)
6f
Number of+securities issued under an
exception in rule 7.2
The Performance Rights will not be quoted or rank
equally with any class of quoted securities.
The underlying fully paid ordinary shares allocated to
the holder upon vesting of the Performance Rights will
be quoted and rank equally with all other ordinary
shares then on issue in the Company.
Nil
The Performance Rights are issued to the eligible
participants under the Company’s Executive and
Director Incentive Plan.
No
N/A
N/A
N/A
297,100 Performance Rights are issued under the
Listing Rule 10.14 and the issue approved by
shareholders at the AGM of the Company held on 25
October 2019.
N/A

==> picture [162 x 12] intentionally omitted <==

==> picture [92 x 11] intentionally omitted <==

==> picture [61 x 11] intentionally omitted <==

==> picture [82 x 14] intentionally omitted <==

==> picture [154 x 14] intentionally omitted <==

6g
If+securities issued under rule 7.1A,
was issue price at least 75% of 15 day
VWAP as calculated under rule 7.1A.3?
Include the+issue date and both
values. Include the source of the
VWAP calculation.
6h
If+securities were issued under rule
7.1A for non-cash consideration, state
date
on
which
valuation
of
consideration was released to ASX
Market Announcements
6i
Calculate the entity’s remaining issue
capacity under rule 7.1 and rule 7.1A –
complete Annexure 1 and release to
ASX Market Announcements
7
+Issue dates
Note: The issue date may be prescribed by ASX (refer
to the definition of issue date in rule 19.12). For
example, the issue date for a pro rata entitlement issue
must comply with the applicable timetable in Appendix
7A.
Cross reference: item 33 of Appendix 3B.
8
Number and+class of all+securities
quoted
on
ASX
(including
the
+securities in section 2 if applicable)

N/A
N/A
See Annexure 1
29 October 2019
Number +Class
89,808,943 Ordinary
Paid
Fully
Shares

==> picture [162 x 12] intentionally omitted <==

==> picture [61 x 11] intentionally omitted <==

==> picture [95 x 11] intentionally omitted <==

==> picture [82 x 14] intentionally omitted <==

==> picture [154 x 14] intentionally omitted <==

9
Number and+class of all+securities not
quoted
on
ASX
(including
the
+securities in section 2 if applicable)
10
Dividend policy (in the case of a trust,
distribution policy) on the increased
capital (interests)
Number +Class
218,551
1,164,237
Nil
Nil
1,382,788
Performance Rights
Balance brought forward
at 28/10/2019
Movements in
Performance Rights
since last Appendix 3B
(30.09.2019)
Issued
Lapsed & Forfeited
Exercised
Balance (current) of
Performance Rights
Holders of the Performance Rights are not eligible to
receive dividends until vesting and fully paid ordinary
shares are issued, at which time the dividend policy
will be the same as that on all existing quoted fully paid
ordinary shares.

Part 2 - Pro rata issue

11
Is security holder approval required?
12
Is the issue renounceable or non-
renounceable?
13
Ratio in which the+securities will be
offered
14
+Class of+securities to which the offer
relates
15
+Record date to determine entitlements
16
Will holdings on different registers (or
subregisters)
be
aggregated
for
calculating entitlements?
17
Policy for deciding entitlements in
relation to fractions
N/A
N/A
N/A
N/A
N/A
N/A
N/A

==> picture [162 x 12] intentionally omitted <==

==> picture [92 x 11] intentionally omitted <==

==> picture [61 x 11] intentionally omitted <==

==> picture [82 x 14] intentionally omitted <==

==> picture [154 x 14] intentionally omitted <==

18
Names of countries in which the entity
has security holders who will not be sent
new offer documents
Note: Security holders must be told how their entitlements
are to be dealt with.
Cross reference: rule 7.7.
19
Closing date for receipt of acceptances
or renunciations
N/A
N/A

==> picture [162 x 12] intentionally omitted <==

==> picture [61 x 11] intentionally omitted <==

==> picture [95 x 11] intentionally omitted <==

==> picture [82 x 14] intentionally omitted <==

==> picture [154 x 14] intentionally omitted <==

20
Names of any underwriters
21
Amount of any underwriting fee or
commission
22
Names of any brokers to the issue
23
Fee or commission payable to the
broker to the issue
24
Amount of any handling fee payable to
brokers who lodge acceptances or
renunciations on behalf of security
holders
25
If the issue is contingent on security
holders’ approval, the date of the
meeting
26
Date entitlement and acceptance form
and offer documents will be sent to
persons entitled
27
If the entity has issued options, and the
terms entitle option holders to participate
on exercise, the date on which notices
will be sent to option holders
28
Date rights trading will begin (if
applicable)
29
Date rights trading will end (if applicable)
30
How do security holders sell their
entitlements_in full_through a broker?
31
How do security holders sell_part_of their
entitlements through a broker and
accept for the balance?
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

==> picture [162 x 12] intentionally omitted <==

==> picture [92 x 11] intentionally omitted <==

==> picture [61 x 11] intentionally omitted <==

==> picture [82 x 14] intentionally omitted <==

==> picture [154 x 14] intentionally omitted <==

32 How do security holders dispose of their entitlements (except by sale through a broker)? 33 +Issue date

N/A N/A

Part 3 - Quotation of securities

You need only complete this section if you are applying for quotation of securities

34 Type of[+] securities ( tick one ) (a) +Securities described in Part 1

  • (b)[All other ][+][securities ]

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

Entities that have ticked box 34(a)

Additional securities forming a new class of securities

Tick to indicate you are providing the information or documents

35[If the ] +securities, and the number and percentage of additional[+][securities are ][+][equity securities, the names of the 20 largest holders of the additional ] +securities held by those holders 36[If the ][+][securities are ][+][equity securities, a distribution schedule of the additional ][+][securities setting ] out the number of holders in the categories 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001 and over

37[A copy of any trust deed for the additional ][+][securities ]

==> picture [162 x 12] intentionally omitted <==

==> picture [61 x 11] intentionally omitted <==

==> picture [95 x 11] intentionally omitted <==

==> picture [82 x 14] intentionally omitted <==

==> picture [154 x 14] intentionally omitted <==

Entities that have ticked box 34(b)

38
Number
of
+securities
for
which
+quotation is sought
39
+Class of+securities for which quotation
is sought
40
Do the+securities rank equally in all
respects from the+issue date with an
existing+class of quoted+securities?
If the additional+securities do not rank
equally, please state:
 the date from which they do
 the extent to which they participate
for the next dividend, (in the case of
a trust, distribution) or interest
payment
 the extent to which they do not rank
equally, other than in relation to the
next dividend, distribution or interest
payment
41
Reason for request for quotation now
Example: In the case of restricted securities, end of
restriction period
(if issued upon conversion of another
+security, clearly identify that other
+security)
42
Number and+class of all+securities
quoted on ASX (_including_the+securities
in clause 38)
N/A
N/A
N/A
N/A
Number +Class
N/A

==> picture [162 x 12] intentionally omitted <==

==> picture [92 x 11] intentionally omitted <==

==> picture [61 x 11] intentionally omitted <==

==> picture [82 x 14] intentionally omitted <==

==> picture [154 x 14] intentionally omitted <==

Quotation agreement

  • 1 +Quotation of our additional +securities is in ASX’s absolute discretion. ASX may quote the +securities on any conditions it decides.

  • 2 We warrant the following to ASX.

  • The issue of the[+] securities to be quoted complies with the law and is not for an illegal purpose.

  • There is no reason why those[+] securities should not be granted[+] quotation.

  • An offer of the[+] securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

  • Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any[+] securities to be quoted and that no-one has any right to return any[+] securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the[+] securities be quoted.

  • If we are a trust, we warrant that no person has the right to return the[+] securities to be quoted under section 1019B of the Corporations Act at the time that we request that the[+] securities be quoted.

  • 3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

  • 4 We give ASX the information and documents required by this form. If any information or document is not available now, we will give it to ASX before[+] quotation of the[+] securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

Sign here: ............................................................ Date: 29 October 2019 Company secretary Print name: Mark Licciardo == == == == ==

==> picture [162 x 12] intentionally omitted <==

==> picture [61 x 11] intentionally omitted <==

==> picture [95 x 11] intentionally omitted <==

==> picture [82 x 14] intentionally omitted <==

==> picture [154 x 14] intentionally omitted <==

Appendix 3B – Annexure 1

Calculation of placement capacity under rule 7.1 and rule 7.1A for eligible entities

Introduced 01/08/12 Amended 04/03/13

Part 1

Rule 7.1 – Issues exceeding 15% of capital

Step 1: Calculate “A”, the base figure from which the placement capacity is calculated

==> picture [404 x 382] intentionally omitted <==

----- Start of picture text -----

Insert number of fully paid [+] ordinary securities on 50,463,937
issue 12 months before the [+] issue date or date of
agreement to issue
Add the following:
• Number of fully paid [+] ordinary securities issued
109,276 shares (issued 30.09.2019)
in that 12 month period under an exception in
rule 7.2 17,098,407 shares (issued 28.02.2019)
19,737,323 shares (issued 15.02.2019)
• Number of fully paid [+] ordinary securities issued
in that 12 month period with shareholder
approval
• Number of partly paid [+] ordinary securities that
became fully paid in that 12 month period
Note:
• Include only ordinary securities here – other
classes of equity securities cannot be added
• Include here (if applicable) the securities the
subject of the Appendix 3B to which this form is
annexed
• It may be useful to set out issues of securities
on different dates as separate line items
Subtract the number of fully paid [+] ordinary Nil
securities cancelled during that 12 month period
“A” 87,408,943
----- End of picture text -----

==> picture [162 x 12] intentionally omitted <==

==> picture [92 x 11] intentionally omitted <==

==> picture [61 x 11] intentionally omitted <==

==> picture [82 x 14] intentionally omitted <==

==> picture [154 x 14] intentionally omitted <==

Step 2: Calculate 15% of “A”

Step 2: Calculate 15% of “A” Step 2: Calculate 15% of “A”
“B” 0.15
[Note: this value cannot be changed]
Multiply“A” by 0.15 13,111,341
Step 3: Calculate “C”, the amount of placement capacity under rule 7.1 that has
already been used
Insertnumber of+equity securities issued or
agreed to be issued in that 12 month period_not_
counting_those issued:

Under an exception in rule 7.2

Under rule 7.1A

With security holder approval under rule 7.1 or
rule 7.4
_Note:


This applies to equity securities, unless
specifically excluded – not just ordinary
securities

Include here (if applicable) the securities the
subject of the Appendix 3B to which this form is
annexed

It may be useful to set out issues of securities
on different dates as separate line items
1,164,237 Performance Rights (Issued pursuant to
this Appendix 3B of 28 October 2019)
2,400,000 shares (issued 01.03.2019)
489,292 Performance Rights (issued 16.11.2018)
“C” 4,053,529
Step 4: Subtract “C” from [“A” x “B”] to calculate remaining placement capacity
under rule 7.1
“A” x 0.15
Note: number must be same as shown in Step 2
13,111,341
Subtract“C”
Note: number must be same as shown in Step 3
4,053,529
Total[“A” x 0.15] – “C” 9,057,812_[Note: this is the remaining placement_
capacity under rule 7.1]

==> picture [162 x 12] intentionally omitted <==

==> picture [61 x 11] intentionally omitted <==

==> picture [95 x 11] intentionally omitted <==

==> picture [82 x 14] intentionally omitted <==

==> picture [154 x 14] intentionally omitted <==

Part 2

Rule 7.1A – Additional placement capacity for eligible entities

Step 1: Calculate “A”, the base figure from which the placement capacity is calculated

“A” N/A Note: number must be same as shown in Step 1 of Part 1 Step 2: Calculate 10% of “A” “D” 0.10 Note: this value cannot be changed Multiply “A” by 0.10 N/A Step 3: Calculate “E”, the amount of placement capacity under rule 7.1A that has already been used

Insert number of[+] equity securities issued or agreed to be issued in that 12 month period under rule 7.1A Notes: • This applies to equity securities – not just ordinary securities • Include here – if applicable – the securities the subject of the Appendix 3B to which this form is annexed • Do not include equity securities issued under rule 7.1 (they must be dealt with in Part 1), or for which specific security holder approval has been obtained • It may be useful to set out issues of securities on different dates as separate line items “E” N/A

==> picture [162 x 12] intentionally omitted <==

==> picture [92 x 11] intentionally omitted <==

==> picture [61 x 11] intentionally omitted <==

==> picture [82 x 14] intentionally omitted <==

==> picture [154 x 14] intentionally omitted <==

Step 4: Subtract “E” from [“A” x “D”] to calculate remaining placement capacity under rule 7.1A

Step 4: Subtract “E” from [“A” x “D”] to calculate remaining placement capacity
under rule 7.1A
Step 4: Subtract “E” from [“A” x “D”] to calculate remaining placement capacity
under rule 7.1A
“A” x 0.10
Note: number must be same as shown in Step 2
N/A
Subtract“E”
Note: number must be same as shown in Step 3
N/A
Total[“A” x 0.10] – “E” N/A
Note: this is the remaining placement capacity under
rule 7.1A

==> picture [162 x 12] intentionally omitted <==

==> picture [61 x 11] intentionally omitted <==

==> picture [92 x 11] intentionally omitted <==